Company: OCEA
Filing Date: 2025-02-26
Form Type: DEF 14A
Source: 0001493152-25-008279
Chunk: 24

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-26
Form: DEF 14A
Chunk 24
---
 stock-based compensation expense for the options awards to non-employee directors as discussed 
 above.                                                                                                                                   |

| 20 |

As of December 31, 2023, there was $1.6 million of unamortized stock-based compensation expense, to be recognized over a weighted-average period of approximately 2.1 years. As of 2024, __________

The following table provides information with respect to options outstanding under our Plan as of December 31, 2023:

| Plan category                      |     | Number        
 of            
 securities to 
 be issued     
 upon exercise 
 of            
 outstanding   
 options       |        |     | Weighted-      
 average        
 exercise price 
 of             
 outstanding    
 options        |       |     | Number        
 of            
 securities    
 remaining     
 available for 
 future        
 issuance      |           |
|:-----------------------------------|:----|:--------------|-------:|:----|:---------------|------:|:----|:--------------|----------:|
| Equity compensation plans approved 
 by security holders                |     |               | 76,114 |     | $              | 41.75 |     |               | 2,181,280 |
| Equity compensation plans          
 not approved by security holders   |     |               |      - |     |                |     - |     |               |         - |
| Total                              |     |               | 76,114 |     | $              | 41.75 |     |               | 2,181,280 |

Non-Employee Director Remuneration Policy

To be determined by the Board during 2025.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

We have adopted a written related-person transactions policy that sets forth our policies and procedures regarding the identification, review, consideration and oversight of “related-party transactions.” For purposes of our policy only, and not for purposes of required disclosure, which will be all related party transactions, even if less than $120,000, a “related-party transaction” is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and any “related party” are participants involving an amount that exceeds $120,000.

Transactions involving compensation for services provided to us as an employee, consultant or director are not considered related-person transactions under this policy. A related party is any executive officer, director or a holder of more than five percent of our common shares, including any of their immediate family members and any entity owned or controlled by